60/100BBlackrock stock forecast 2026–2029What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Blackrock is 1,341.45, 9.8% above the current price of 1,222.26. Their targets range from 1,250.00 to 1,468.00.
Of the 12 firms that rated Blackrock in the past 12 months, 12 rate it buy or strong buy, 0 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 1,250.00 to 1,468.00, with an average of 1,341.45.
| Buy | 12 | |
| Hold | 0 | |
| Sell | 0 |
12-month price target
| Highest target | 1,468.00 |
| Average target | 1,341.45 |
| Lowest target | 1,250.00 |
| Current price | 1,222.26 |
Blackrock price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Blackrock price target and rating?
How analysts rate Blackrock, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
12 of 12 firms rate it buy now, against 11 of 14 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Blackrock analyst upgrades, downgrades and price targets
The latest rating change came on 20 October 2026, when TD Cowen upgraded Blackrock from Hold to Buy. The most recent new target came from Jefferies on 28 October 2026: 1,341.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 28 Oct 2026 | Jefferies Daniel Fannon | — | 1,351.00 → 1,341.00 | -0.7% | 1,136.05 |
| 20 Oct 2026 | BlackRock Bill Katz | — | 1,364.00 → 1,405.00 | +3.0% | 1,124.60 |
| 20 Oct 2026 | TD Cowen | Upgraded · Hold → Buy | — | — | — |
| 19 Oct 2026 | BMO Capital | Reiterated · Outperform | 1,200.00 → 1,350.00 | +12.5% | 1,128.88 |
| 15 Oct 2026 | Truist Financial | — | 1,310.00 | — | 1,093.53 |
| 15 Oct 2026 | Wells Fargo Daniel Welden | Reiterated · Overweight | 1,230.00 → 1,250.00 | +1.6% | 1,073.79 |
| 15 Oct 2026 | UBS | Reiterated · Buy | 1,277.00 → 1,300.00 | +1.8% | 1,073.79 |
| 15 Oct 2026 | Barclays Benjamin Budish | Reiterated · Overweight | 1,420.00 → 1,410.00 | -0.7% | 1,073.79 |
| 13 Oct 2026 | Morgan Stanley | Reiterated · Overweight | 1,479.00 → 1,468.00 | -0.7% | 1,069.14 |
| 9 Oct 2026 | Evercore ISI Glenn Schorr | Reiterated · Outperform | 1,260.00 → 1,275.00 | +1.2% | 1,070.96 |
| 8 Oct 2026 | Wells Fargo Daniel Welden | Reiterated · Overweight | 1,245.00 → 1,230.00 | -1.2% | 1,069.63 |
| 7 Oct 2026 | UBS | Reiterated · Buy | 1,320.00 → 1,277.00 | -3.3% | 1,059.73 |
| 7 Oct 2026 | Barclays Benjamin Budish | Reiterated · Overweight | 1,450.00 → 1,420.00 | -2.1% | 1,079.42 |
| 1 Oct 2026 | Wells Fargo | — | 1,245.00 | — | 1,064.36 |
| 25 Sept 2026 | Morgan Stanley | Reiterated · Overweight | 1,488.00 → 1,479.00 | -0.6% | 1,073.45 |
| 10 Aug 2026 | Evercore ISI Glenn Schorr | Reiterated · Outperform | 1,145.00 → 1,260.00 | +10.0% | 1,132.32 |
| 16 Jul 2026 | Deutsche Bank | — | 1,380.00 → 1,258.00 | -8.8% | 1,105.42 |
| 16 Jul 2026 | UBS Michael Brown | Reiterated · Buy | 1,235.00 → 1,320.00 | +6.9% | 1,109.10 |
| 16 Jul 2026 | Goldman Sachs | — | 1,313.00 → 1,389.00 | +5.8% | 1,104.00 |
| 16 Jul 2026 | Morgan Stanley Michael Cyprys | Reiterated · Overweight | 1,383.00 → 1,488.00 | +7.6% | 1,093.40 |
| 16 Jul 2026 | JP Morgan | Upgraded · Neutral → Overweight | — | — | — |
| 15 Jul 2026 | Barclays | — | 1,350.00 → 1,450.00 | +7.4% | 1,093.40 |
| 14 Jul 2026 | Morgan Stanley Michael Cyprys | Reiterated · Overweight | 1,430.00 → 1,383.00 | -3.3% | 1,033.98 |
| 10 Jul 2026 | Evercore ISI | Reiterated · Outperform | 1,140.00 → 1,145.00 | +0.4% | 1,040.29 |
| 26 Jun 2026 | Morgan Stanley Michael Cyprys | Reiterated · Overweight | 1,393.00 → 1,430.00 | +2.7% | 974.19 |
| 8 Jun 2026 | Evercore ISI | — | 1,220.00 → 1,140.00 | -6.6% | 998.24 |
| 15 Apr 2026 | Evercore ISI | Reiterated · Outperform | 1,200.00 → 1,220.00 | +1.7% | 1,054.56 |
| 15 Apr 2026 | Morgan Stanley | Reiterated · Overweight | 1,514.00 → 1,393.00 | -8.0% | 1,054.56 |
| 10 Apr 2026 | BMO Capital | Reiterated · Outperform | 1,200.00 | — | 992.81 |
| 9 Apr 2026 | UBS | Reiterated · Buy | 1,280.00 → 1,235.00 | -3.5% | 1,001.62 |
| 23 Feb 2026 | UBS | Upgraded · Neutral → Buy | — | — | — |
| 23 Jan 2026 | BlackRock Mikhail Paramonov | — | 1,209.00 → 1,364.00 | +12.8% | 1,129.91 |
| 23 Jan 2026 | Freedom Broker | Upgraded · Hold → Buy | — | — | — |
| 16 Jan 2026 | Deutsche Bank | — | 1,312.00 → 1,380.00 | +5.2% | 1,175.97 |
| 16 Jan 2026 | UBS Michael Brown | Reiterated · Neutral | 1,218.00 → 1,280.00 | +5.1% | 1,156.65 |
| 16 Jan 2026 | Barclays | Reiterated · Overweight | 1,300.00 → 1,350.00 | +3.8% | 1,156.65 |
| 16 Jan 2026 | Jefferies Daniel Fannon | — | 1,351.00 | — | 1,156.65 |
| 14 Jan 2026 | BlackRock | — | 1,209.00 | — | 1,089.54 |
| 14 Jan 2026 | TD Cowen | Downgraded · Buy → Hold | — | — | — |
| 12 Jan 2026 | UBS | Reiterated · Neutral | 1,180.00 → 1,218.00 | +3.2% | 1,085.91 |
| 8 Jan 2026 | Barclays | Reiterated · Overweight | 1,340.00 → 1,300.00 | -3.0% | 1,075.09 |
| 17 Dec 2025 | Morgan Stanley | Reiterated · Overweight | 1,486.00 → 1,514.00 | +1.9% | 1,081.30 |
| 12 Dec 2025 | Barclays | Reiterated · Overweight | 1,360.00 → 1,340.00 | -1.5% | 1,101.90 |
| 11 Dec 2025 | UBS Michael Brown | — | 980.00 → 1,180.00 | +20.4% | 1,083.36 |
| 9 Dec 2025 | Goldman Sachs Alexander Blostein | — | 1,115.00 → 1,313.00 | +17.8% | 1,070.94 |
Blackrock EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Blackrock's EPS to grow 35.8% a year until 2027, faster than over the last 5 years (2.1% a year) and the last 3 years (1.3%).
Analysts expect Blackrock's revenue to grow 14.8% a year until 2028, faster than over the last 5 years (8.4% a year) and the last 3 years (10.7%).
Revenue
EPS
Does Blackrock beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 8.1% off the result, either way, and their revenue estimate 2.3%, over the last 12 quarters.
- EPS beats
- 75 / 95
- Revenue beats
- 69 / 95
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +8.1%
- Since
- January 2000
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 14 Oct 2026 | 14.32 | 15.93 | +11.2% | 7.42B | 7.75B | +4.5% |
| Q2 FY2026 | 15 Jul 2026 | 12.69 | 13.91 | +9.6% | 6.73B | 7.08B | +5.3% |
| Q1 FY2026 | 14 Apr 2026 | 11.65 | 12.53 | +7.6% | 6.55B | 6.70B | +2.2% |
| Q4 FY2025 | 15 Jan 2026 | 12.24 | 13.16 | +7.5% | 6.76B | 7.01B | +3.7% |
| Q3 FY2025 | 14 Oct 2025 | 11.36 | 11.55 | +1.7% | 6.33B | 6.51B | +2.8% |
| Q2 FY2025 | 15 Jul 2025 | 10.78 | 12.05 | +11.8% | 5.45B | 5.42B | -0.5% |
| Q1 FY2025 | 11 Apr 2025 | 10.08 | 11.30 | +12.1% | 5.29B | 5.28B | -0.3% |
| Q4 FY2024 | 15 Jan 2025 | 11.27 | 11.93 | +5.9% | 5.57B | 5.68B | +2.0% |
| Q3 FY2024 | 11 Oct 2024 | 10.33 | 11.46 | +10.9% | 5.03B | 5.20B | +3.2% |
| Q2 FY2024 | 15 Jul 2024 | 9.93 | 10.36 | +4.3% | 4.85B | 4.81B | -0.9% |
| Q1 FY2024 | 12 Apr 2024 | 9.35 | 9.81 | +4.9% | 4.66B | 4.73B | +1.5% |
| Q4 FY2023 | 12 Jan 2024 | 8.84 | 9.66 | +9.3% | 4.65B | 4.63B | -0.4% |
Blackrock stock price 2026–2029: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Blackrock's earnings grow at the 16.4% a year analysts expect to FY2027, then 15.0% a year, it would earn about 86.09 a share in FY2029. At the P/E it has traded at over the last five years (20.7 to 29.9) that is 1,778.14 to 2,571.82 a share, or 2,120.03 at its average P/E of 24.6. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 57.75 | 1,192.81 | 1,422.16 | 1,725.24 |
| FY2027 | 65.10 | 1,344.53 | 1,603.04 | 1,944.67 |
| FY2028 (extrapolated) | 74.86 | 1,546.21 | 1,843.50 | 2,236.37 |
| FY2029 (extrapolated) | 86.09 | 1,778.14 | 2,120.03 | 2,571.82 |
Each year's EPS is the analysts' consensus to FY2027; the years after grow 15.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (20.7, 24.6, 29.9).
Is Blackrock stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Blackrock's P/E of 27.4 is near the top of its 5-year range (13.8 to 30.6, median 22.0). Analysts expect faster growth than in recent years, which can explain part of the high P/E. Buyers pay less for each point of growth than usual: a PEG of 0.8 on expected growth against 10.6 on its median P/E and past five years' growth. Growing 35.8% a year, Blackrock earns a P/E of 25.0 at a PEG of 1 (at most 25): × the next twelve months' EPS of 64.09, a fair value of 1,602.30; the price, 1,222.26, is 23.7% below it. Its forward P/E, on the consensus for FY2026, is 21.2.
Fair value on growth is a P/E equal to the EPS growth analysts expect a year (a PEG of 1, at most 25) times the earnings per share of the next twelve months; the ends of the bar are a PEG of 0.75 and 1.25 (a P/E of 18.8 and 31.3). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 27.42
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 22.00
- Five-year P/E range
- 13.8 – 30.6
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 21.16
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 1.67
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +9.8%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 194.150 | 384.66163Price 194.152,644 | +98.1% | |
| 151.500 | 297.58169Price 151.50471 | +96.4% | |
| 43.415 | 82.9546Price 43.42165 | +91.1% | |
| 160.210 | 305.52160Price 160.21396 | +90.7% | |
| 213.480 | 405.47304Price 213.48507 | +89.9% | |
| 159.250 | 300.34225Price 159.25375 | +88.6% | |
| 164.480 | 308.95212Price 164.48442 | +87.8% |
Furthest below the fair value on each stock's page, updated every day.